首页 > 最新文献

Journal de Pharmacie Clinique最新文献

英文 中文
Bladder tumor: tolerance of patients treated with BCG immuntherapy 膀胱肿瘤:卡介苗免疫治疗患者的耐受性
Q4 Medicine Pub Date : 2023-06-01 DOI: 10.1684/jpc.2023.0519
Mirette Othman, F. Sellami, M. Chakroun, A. Saadi, Z. Ouahchi, A. Bouzouita, N. Hasni, M. Chebil
{"title":"Bladder tumor: tolerance of patients treated with BCG immuntherapy","authors":"Mirette Othman, F. Sellami, M. Chakroun, A. Saadi, Z. Ouahchi, A. Bouzouita, N. Hasni, M. Chebil","doi":"10.1684/jpc.2023.0519","DOIUrl":"https://doi.org/10.1684/jpc.2023.0519","url":null,"abstract":"","PeriodicalId":35917,"journal":{"name":"Journal de Pharmacie Clinique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42795564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isoniazid acetylator phenotype and its clinical impact in patients treated with first-line antituberculosis drugs 异烟肼乙酰化物表型及其对一线抗结核药物治疗患者的临床影响
Q4 Medicine Pub Date : 2023-06-01 DOI: 10.1684/jpc.2023.0520
R. Bougossa, W. Marrakchi, N. B. Fadhel, M. Chakroun
{"title":"Isoniazid acetylator phenotype and its clinical impact in patients treated with first-line antituberculosis drugs","authors":"R. Bougossa, W. Marrakchi, N. B. Fadhel, M. Chakroun","doi":"10.1684/jpc.2023.0520","DOIUrl":"https://doi.org/10.1684/jpc.2023.0520","url":null,"abstract":"","PeriodicalId":35917,"journal":{"name":"Journal de Pharmacie Clinique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48004817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of daratumumab in combination with lenalidomide and dexamethasone: a real life study daratumumab与来那度胺和地塞米松联合使用:一项现实生活研究
Q4 Medicine Pub Date : 2023-06-01 DOI: 10.1684/jpc.2023.0522
A. Deĺepine, I. Ferry, L. Escalup, S. Glaisner
{"title":"Use of daratumumab in combination with lenalidomide and dexamethasone: a real life study","authors":"A. Deĺepine, I. Ferry, L. Escalup, S. Glaisner","doi":"10.1684/jpc.2023.0522","DOIUrl":"https://doi.org/10.1684/jpc.2023.0522","url":null,"abstract":"","PeriodicalId":35917,"journal":{"name":"Journal de Pharmacie Clinique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47087800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving the quality of publications in and advancing the entire paradigms of clinical and social pharmacy practice research: the Granada statements 提高出版物的质量和推进临床和社会药学实践研究的整个范式:格拉纳达声明
Q4 Medicine Pub Date : 2023-06-01 DOI: 10.1684/jpc.2023.0523
Fernando Fernandez-Llimos, Shane Desselle, Derek Stewart, Victoria Garcia-Cardenas, Zaheer-Ud-Din Babar, Christine Bond, Ana Dago, Ramune Jacobsen, Lotte Stig Nørgaard, Carlo Polidori, Manuel Sanchez-Polo, Bernardo Santos-Ramos, Natalia Shcherbakova, Fernanda S. Tonin
{"title":"Improving the quality of publications in and advancing the entire paradigms of clinical and social pharmacy practice research: the Granada statements","authors":"Fernando Fernandez-Llimos, Shane Desselle, Derek Stewart, Victoria Garcia-Cardenas, Zaheer-Ud-Din Babar, Christine Bond, Ana Dago, Ramune Jacobsen, Lotte Stig Nørgaard, Carlo Polidori, Manuel Sanchez-Polo, Bernardo Santos-Ramos, Natalia Shcherbakova, Fernanda S. Tonin","doi":"10.1684/jpc.2023.0523","DOIUrl":"https://doi.org/10.1684/jpc.2023.0523","url":null,"abstract":"","PeriodicalId":35917,"journal":{"name":"Journal de Pharmacie Clinique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136177880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vienne, 6-9 novembre 2022 维也纳,2022年11月6日至9日
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.1684/jpc.2023.0518
{"title":"Vienne, 6-9 novembre 2022","authors":"","doi":"10.1684/jpc.2023.0518","DOIUrl":"https://doi.org/10.1684/jpc.2023.0518","url":null,"abstract":"","PeriodicalId":35917,"journal":{"name":"Journal de Pharmacie Clinique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49117025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Introduction of pre-diluted morphine in a healthcare facility: taking into account the wishes of the caregivers so as not to make a painful change of market 在医疗机构中引入预先稀释的吗啡:考虑到护理人员的意愿,以免造成痛苦的市场变化
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.1684/jpc.2023.0512
Sophie Girard, C. Stamm, F. Aubrun, C. Paillet
{"title":"Introduction of pre-diluted morphine in a healthcare facility: taking into account the wishes of the caregivers so as not to make a painful change of market","authors":"Sophie Girard, C. Stamm, F. Aubrun, C. Paillet","doi":"10.1684/jpc.2023.0512","DOIUrl":"https://doi.org/10.1684/jpc.2023.0512","url":null,"abstract":"","PeriodicalId":35917,"journal":{"name":"Journal de Pharmacie Clinique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42391838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral glucocorticoids in multisystem inflammatory syndrome in children patients: tapering schedules, return home and risks of relapse 口服糖皮质激素治疗儿童多系统炎症综合征:减量计划、回家治疗和复发风险
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.1684/jpc.2023.0511
Émilie Cohen, J. Agar, Clémence Guillot, A. Rouault, N. Ouldali, A. Faye, J. Rouprêt-Serzec, Christelle Moreau
Introduction. Pediatric Inflammatory Multisystem Syndrome (MIS-C) is treated by the administration of intravenous polyvalent immunoglobulins and corticosteroids, as recommended by the French National Authority for Health (Haute Autorite de Sante) and the WHO (World Health Organization). However, no corticosteroids tapering schedule has been validated and patients returning home are not properly supervised by a pharmacist. Aims. Identify the occurrence of relapses according to the corticosteroid tapering schedules prescribed on return home. Analyze patients' reported compliance to these decreases. Identify possible links between poor compliance and relapse. Patients and method. This retrospective study analyzes the digital medical records on Orbis software of patients who have been hospitalized for a MIS-C between April 2020 and June 2021 in a French pediatric hospital. Results. 66 MIS-C patients were included. 54 were treated by intravenous corticotherapy 2 mg/kg/day, 2 with 1 mg/kg/day, 10 have not received any. Five different tapering schedules were prescribed, 3 patients relapsed. Recurrence of relapse is not significantly related to the tapering schedule followed (p = 0,759). 6/54 (11 %) patients wrongly followed their tapering schedules. Among them, 2 relapsed, versus 1/48 (2 %) among compliers (p = 0.029;OR = 0.04). Discussion - Conclusion. This study emphasizes the difficulty for a patient to comply with corticosteroids tapering schedule without supervision, as well as the subsequent rebound risks. Pharmaceutical counseling for patients returning home after hospitalization will be promoted to ensure better communication and patients' understanding and compliance.Copyright © 2023 John Libbey Eurotext. All rights reserved.
介绍。根据法国国家卫生管理局(Haute Autorite de Sante)和世界卫生组织(WHO)的建议,通过静脉注射多价免疫球蛋白和皮质类固醇治疗小儿炎症多系统综合征(MIS-C)。然而,没有皮质类固醇减量计划得到证实,患者回家时没有得到药剂师的适当监督。目标根据回家时规定的皮质类固醇减量时间表确定复发的发生。分析患者对这些减少的依从性报告。确定不良依从性和复发之间的可能联系。患者和方法。本回顾性研究分析了法国一家儿科医院在2020年4月至2021年6月期间因misc住院的患者在Orbis软件上的数字医疗记录。结果:纳入66例misc患者。54例接受静脉皮质治疗2mg /kg/天,2例接受1mg /kg/天,10例未接受任何静脉皮质治疗。5种不同的减量方案,3例复发。复发率与减量计划无显著相关(p = 0.759)。6/54(11%)患者错误地遵循了减量计划。其中2例复发,合组患者复发1/48 (2%)(p = 0.029;OR = 0.04)。讨论-结论。本研究强调了患者在没有监督的情况下遵守糖皮质激素减量计划的困难,以及随后的反弹风险。促进患者住院后回家的药物咨询,确保更好的沟通和患者的理解和依从性。版权所有©2023 John Libbey Eurotext。版权所有。
{"title":"Oral glucocorticoids in multisystem inflammatory syndrome in children patients: tapering schedules, return home and risks of relapse","authors":"Émilie Cohen, J. Agar, Clémence Guillot, A. Rouault, N. Ouldali, A. Faye, J. Rouprêt-Serzec, Christelle Moreau","doi":"10.1684/jpc.2023.0511","DOIUrl":"https://doi.org/10.1684/jpc.2023.0511","url":null,"abstract":"Introduction. Pediatric Inflammatory Multisystem Syndrome (MIS-C) is treated by the administration of intravenous polyvalent immunoglobulins and corticosteroids, as recommended by the French National Authority for Health (Haute Autorite de Sante) and the WHO (World Health Organization). However, no corticosteroids tapering schedule has been validated and patients returning home are not properly supervised by a pharmacist. Aims. Identify the occurrence of relapses according to the corticosteroid tapering schedules prescribed on return home. Analyze patients' reported compliance to these decreases. Identify possible links between poor compliance and relapse. Patients and method. This retrospective study analyzes the digital medical records on Orbis software of patients who have been hospitalized for a MIS-C between April 2020 and June 2021 in a French pediatric hospital. Results. 66 MIS-C patients were included. 54 were treated by intravenous corticotherapy 2 mg/kg/day, 2 with 1 mg/kg/day, 10 have not received any. Five different tapering schedules were prescribed, 3 patients relapsed. Recurrence of relapse is not significantly related to the tapering schedule followed (p = 0,759). 6/54 (11 %) patients wrongly followed their tapering schedules. Among them, 2 relapsed, versus 1/48 (2 %) among compliers (p = 0.029;OR = 0.04). Discussion - Conclusion. This study emphasizes the difficulty for a patient to comply with corticosteroids tapering schedule without supervision, as well as the subsequent rebound risks. Pharmaceutical counseling for patients returning home after hospitalization will be promoted to ensure better communication and patients' understanding and compliance.Copyright © 2023 John Libbey Eurotext. All rights reserved.","PeriodicalId":35917,"journal":{"name":"Journal de Pharmacie Clinique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43920190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
8e Journée scientifique des internes en pharmacie d’Île-de-France, Paris, 30 mars 2023 2023年3月30日,巴黎ile -de- france,第8届药学实习生科学日
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.1684/jpc.2023.0513
Ariane Bros, Clémentine Baguet, Olivia Gautier, Benjamin Querin
{"title":"8e Journée scientifique des internes en pharmacie d’Île-de-France, Paris, 30 mars 2023","authors":"Ariane Bros, Clémentine Baguet, Olivia Gautier, Benjamin Querin","doi":"10.1684/jpc.2023.0513","DOIUrl":"https://doi.org/10.1684/jpc.2023.0513","url":null,"abstract":"","PeriodicalId":35917,"journal":{"name":"Journal de Pharmacie Clinique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45524865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nouvelles approches pour une meilleure prise en considération de la valeur dans les décisions en matière d'évaluation des technologies de santé (ETS) 在卫生技术评估决策中更好地考虑价值的新方法
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.1684/jpc.2023.0516
Y. Certain, F. Simon, P. Gontier
{"title":"Nouvelles approches pour une meilleure prise en considération de la valeur dans les décisions en matière d'évaluation des technologies de santé (ETS)","authors":"Y. Certain, F. Simon, P. Gontier","doi":"10.1684/jpc.2023.0516","DOIUrl":"https://doi.org/10.1684/jpc.2023.0516","url":null,"abstract":"","PeriodicalId":35917,"journal":{"name":"Journal de Pharmacie Clinique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45988007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dispositifs médicaux : innovation et ETS - Réflexions au sujet des marchés publics 医疗设备:创新和ETS -对公共采购的思考
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.1684/jpc.2023.0515
Coline Chea, Anaëlle Choquer, Victor Durieux
{"title":"Dispositifs médicaux : innovation et ETS - Réflexions au sujet des marchés publics","authors":"Coline Chea, Anaëlle Choquer, Victor Durieux","doi":"10.1684/jpc.2023.0515","DOIUrl":"https://doi.org/10.1684/jpc.2023.0515","url":null,"abstract":"","PeriodicalId":35917,"journal":{"name":"Journal de Pharmacie Clinique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67567234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal de Pharmacie Clinique
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1